Recent Advances in Pancreatic Neoplasms

Edited by
March 2022
176 pages
  • ISBN978-3-0365-3499-2 (Hardback)
  • ISBN978-3-0365-3500-5 (PDF)

This book is a reprint of the Special Issue Recent Advances in Pancreatic Neoplasms that was published in

Medicine & Pharmacology
Public Health & Healthcare

Pancreatic neoplasms include different pathological entities with variable biological behavior and different treatment modalities. Surgery and adjuvant therapy are the cornerstones of the therapeutic approach; however, even after radical resection, the majority of patients experience disease recurrence and the prognosis of pancreatic cancer remains dismal.

A multimodal therapeutic approach, based on a combination of neoadjuvant therapy, chemotherapy, radiotherapy, immunotherapy and surgery, appears fundamental to improving the outcomes.

This Special Issue of the Journal of Clinical Medicine, entitled “Recent Advances in Pancreatic Neoplasms”, focuses on possible new strategies to treat pancreatic neoplasms.

  • Hardback
© 2022 by the authors; CC BY-NC-ND license
PIWI proteins; PIWIL3; PIWIL4; pancreatic cancer; EMT; chemoresistance; motility; HNF4A; survival; pancreatic neuroendocrine neoplasm; primary pancreatic carcinoid; serotonin-secreting pancreatic tumour; serotonin-producing pancreatic tumour; pancreatic cancer; neoadjuvant chemotherapy; response; carbohydrate antigen 19-9; fluorodeoxyglucose; pancreatectomy; pancreatic cancer; positron emission tomography; prognosis; standardized uptake value; Pancreatic ductal adenocarcinoma; prognosis; microRNAs; pancreatic fistula; pancreatectomy; pancreatic neoplasm; renal cell carcinoma; pancreatic neoplasms; pancreatectomy; PET-CT scan; pancreatic cancer; pancreatic ductal adenocarcinoma; pancreatic cancer prognosis; completion total pancreatectomy; pancreatic ductal adenocarcinoma; pooled analysis; recurrent pancreatic cancer; repeated pancreatectomy; survival; pancreas; neuropathy; taxanes; survival; biomarker; C-reactive protein to albumin ratio; inflammation; intraductal papillary mucinous neoplasm; modified Glasgow prognostic score; neutrophyl lymphocite ratio; pancreatic cancer; platelet-to-lymphocyte ratio; robotic pancreatic surgery; pancreato-gastrostomy; pancreatic fistula; low muscle mass; sarcopenia; pancreatic adenocarcinoma; pancreatic cancer; pancreatic surgery; body composition; n/a